Meta-analysis: Drugs in heart failure with preserved ejection fraction
31 Aug, 2017 | 20:33h | UTCCommentary: Heart Failure with Preserved Ejection Fraction: Treatments Compared – MPR (free)
Source: ACP Journal Wise ($)
This study suggests a reduction in all-cause mortality with beta-blocker therapy in patients with heart failure with preserved ejection fraction. The authors recommend further trials to confirm the benefits of beta-blockers in this patient group.